Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bank of America Joins Boys & Girls Clubs to Empower Youth Entrepreneurs for Lemonade Day
-
flynas Celebrates the Launch of Its First Direct Flights Between Riyadh and Moscow
-
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
-
Trump Media Reports Second Quarter 2025 Results
-
CORRECTION – Sony Joins the AR Alliance to Advance the Future of Augmented Reality Wearable Devices
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2025
-
TWC Enterprises Limited Announces Second Quarter 2025 Results And Eligible Dividend
-
Opendoor Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
-
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
-
Uniti Completes Merger with Windstream
-
Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
-
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
-
ThreeD Capital Inc. Completes Private Placement Financing
-
Guggenheim Investments Announces August 2025 Closed-End Fund Distributions
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios as of July 31, 2025
-
“Bogotá Accounts for 60% of Foreign Investment in Technology Entering Colombia”
-
Sirona Biochem Update to Shareholders on Financial Status and Operations
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
-
WEBUY GLOBAL LTD Announces Closing of Follow-on Offering
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Toll Brothers to Webcast Its Third Quarter 2025 Earnings Conference Call Live on August 20, 2025 at 8:30 a.m. (ET)
-
Boston Beer Company Announces CEO Transition
-
Net Asset Value Restatement for Innovator International Developed Power Buffer ETF™- August (NYSE Arca: IAUG)
-
NCMS Report Investigates how Employing Telematics Enhances Predictive Maintenance Benefits for Ground Vehicles
-
HODL Unites Dubai and Riyadh for a Landmark Blockchain Roadshow Across the Middle East
-
MarketWise Declares Quarterly and Special Dividend Totaling $0.40 Per Class A Share; Announces Second Quarter 2025 Financial Results Release Date
-
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
-
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.070 per Share
-
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 2Q25
-
Max Power Closes First $2.45 Million in Private Placements With Eric Sprott as Lead Investor
-
Smart Share Global Limited Enters into Definitive Merger Agreement for Going Private Transaction
-
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rumble Announces Timing of Second Quarter 2025 Earnings Release and Conference Call
-
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
-
NuCana Announces ADS Ratio Change
-
Lakeland Fire + Safety Declares Cash Dividend for Third Quarter 2026
-
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
-
Taitron Announces Quarterly Cash Dividend
-
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
-
Banco Comercial Português, S.A. informs about 2025 EU-Wide Stress Test Results
-
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
-
Mandalay Obtains Final Order Approving Arrangement with Alkane
